1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Dubovskii, P.V. Dementieva, D.V. Bocharov, E.V. Utkin, Y.N. Arseniev, A.S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 305 137 149 10.1006/jmbi.2000.4283 11114253 Membrane binding motif of the P-type cardiotoxin. 2001 IX Eur.J.Biochem. EJBCAI 0262 0014-2956 263 152 162 10.1046/j.1432-1327.1999.00478.x Two forms of Cytotoxin II (cardiotoxin) from Naja naja oxiana in Aqueous Solution. Spatial Structures with Tightly Bound Water Molecules 1999 10.2210/pdb1ffj/pdb pdb_00001ffj 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6648.238 CYTOTOXIN 2 1 1 nat polymer 18.015 water 2 nat water CARDIOTOXIN no no LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Central Asian cobra Naja sample 8657 Naja oxiana VENOM database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-01-17 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession 1CB9 is the Solution Structure of Cardiotoxin from Naja oxiana (major form) RCSB Y RCSB 2000-07-25 REL REL HOH water This structure was determined using standard 2D homonuclear techniques. Sites of tightly bound water molecules were determined as in Dementieva et al., Eur.J.Biochem.1999,263,152-162. target function 220 20 2D NOESY TOCSY DQF-COSY ROESY DQF-COSY 2D NOESY TOCSY ROESY DQF-COSY 2D NOESY 0M NaCl 5.5 ambient 318 K 0M NaCl 5.5 ambient 303 K structures are based on a total of 368 NOE-derived constraints, 154 dihedral angle restraints, 248 distance restraints from hydrogen bonds and disulfides torsion angle dynamics 1 fewest violations 3mM Cardiotoxin (cytotoxin II); 120 mM perdeuterated dodecylphosphocholine 90% H2O/10% D2O 3mM Cardiotoxin (cytotoxin II); 120 mM perdeuterated dodecylphosphocholine 100% D2O Varian software collection VNMR 6.1A Xia, T. & Bartels, C. data analysis XEASY 1.2.11 Guentert, P. & Mumenthaler, C. structure solution DYANA 1.5 Guentert, P. & Mumenthaler, C. refinement DYANA 1.5 600 Varian UNITY HOH 61 2 HOH HOH 61 A HOH 62 2 HOH HOH 62 A LEU 1 n 1 LEU 1 A LYS 2 n 2 LYS 2 A CYS 3 n 3 CYS 3 A LYS 4 n 4 LYS 4 A LYS 5 n 5 LYS 5 A LEU 6 n 6 LEU 6 A VAL 7 n 7 VAL 7 A PRO 8 n 8 PRO 8 A LEU 9 n 9 LEU 9 A PHE 10 n 10 PHE 10 A SER 11 n 11 SER 11 A LYS 12 n 12 LYS 12 A THR 13 n 13 THR 13 A CYS 14 n 14 CYS 14 A PRO 15 n 15 PRO 15 A ALA 16 n 16 ALA 16 A GLY 17 n 17 GLY 17 A LYS 18 n 18 LYS 18 A ASN 19 n 19 ASN 19 A LEU 20 n 20 LEU 20 A CYS 21 n 21 CYS 21 A TYR 22 n 22 TYR 22 A LYS 23 n 23 LYS 23 A MET 24 n 24 MET 24 A PHE 25 n 25 PHE 25 A MET 26 n 26 MET 26 A VAL 27 n 27 VAL 27 A ALA 28 n 28 ALA 28 A ALA 29 n 29 ALA 29 A PRO 30 n 30 PRO 30 A HIS 31 n 31 HIS 31 A VAL 32 n 32 VAL 32 A PRO 33 n 33 PRO 33 A VAL 34 n 34 VAL 34 A LYS 35 n 35 LYS 35 A ARG 36 n 36 ARG 36 A GLY 37 n 37 GLY 37 A CYS 38 n 38 CYS 38 A ILE 39 n 39 ILE 39 A ASP 40 n 40 ASP 40 A VAL 41 n 41 VAL 41 A CYS 42 n 42 CYS 42 A PRO 43 n 43 PRO 43 A LYS 44 n 44 LYS 44 A SER 45 n 45 SER 45 A SER 46 n 46 SER 46 A LEU 47 n 47 LEU 47 A LEU 48 n 48 LEU 48 A VAL 49 n 49 VAL 49 A LYS 50 n 50 LYS 50 A TYR 51 n 51 TYR 51 A VAL 52 n 52 VAL 52 A CYS 53 n 53 CYS 53 A CYS 54 n 54 CYS 54 A ASN 55 n 55 ASN 55 A THR 56 n 56 THR 56 A ASP 57 n 57 ASP 57 A LYS 58 n 58 LYS 58 A CYS 59 n 59 CYS 59 A ASN 60 n 60 ASN 60 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O CYS 3 A O CYS 3 A N LYS 12 A N LYS 12 A N ILE 39 A N ILE 39 A O LEU 20 A O LEU 20 A O PHE 25 A O PHE 25 A N LYS 50 A N LYS 50 1 A A H O MET HOH 26 61 1.52 2 A A H O MET HOH 26 61 1.25 2 A A HG O SER VAL 46 49 1.58 4 A A H O MET HOH 26 61 1.39 5 A A H O MET HOH 26 61 1.45 6 A A H O MET HOH 26 61 1.41 7 A A H O MET HOH 26 61 1.59 8 A A H O MET HOH 26 61 1.50 9 A A HG O SER VAL 46 49 1.54 10 A A H O MET HOH 26 61 1.55 11 A A H O MET HOH 26 61 1.40 12 A A O H1 MET HOH 26 61 1.52 12 A A O O MET HOH 26 61 2.02 14 A A H O MET HOH 26 61 1.32 16 A A H O MET HOH 26 61 1.23 16 A A HG O SER VAL 46 49 1.58 17 A A H O MET HOH 26 61 1.19 17 A A N O MET HOH 26 61 2.17 18 A A H O MET HOH 26 61 1.45 19 A A H O MET HOH 26 61 1.21 19 A A HZ2 HD2 LYS ASP 18 40 1.27 20 A A H O MET HOH 26 61 1.24 20 A A N O MET HOH 26 61 2.17 1 A VAL 32 -155.90 87.22 1 A ASN 55 -105.26 63.75 2 A ALA 28 -37.03 -38.49 2 A VAL 32 -157.11 78.58 2 A ASN 55 -108.13 70.35 3 A LEU 6 -40.69 -71.70 3 A VAL 32 -157.41 78.46 3 A ASN 55 -107.53 63.61 4 A VAL 32 -153.07 84.04 4 A ASN 55 -113.87 70.59 5 A ALA 16 -40.18 155.02 5 A ALA 28 -37.14 -39.17 5 A VAL 32 -158.75 84.94 5 A ASN 55 -118.81 63.38 6 A LEU 6 -42.81 -70.23 6 A ALA 16 -48.35 156.07 6 A VAL 32 -152.21 85.45 7 A VAL 32 -156.59 74.41 7 A ASN 55 -103.27 69.03 8 A LEU 6 -39.77 -73.30 8 A ALA 16 -42.30 157.77 8 A VAL 32 -158.35 81.26 9 A ALA 16 -40.31 157.36 9 A HIS 31 -142.21 57.54 9 A ASN 55 -109.77 65.90 10 A LEU 6 -40.75 -72.13 10 A VAL 32 -151.68 87.29 10 A ASN 55 -110.81 66.10 11 A ALA 16 -44.69 158.74 11 A VAL 32 -155.12 83.94 12 A LYS 5 -75.59 -167.04 12 A VAL 32 -156.59 80.75 12 A CYS 54 -171.41 143.27 12 A ASN 55 -103.61 62.12 13 A ALA 16 -43.49 163.41 13 A ASN 55 -110.87 66.27 14 A VAL 32 -157.54 84.02 15 A HIS 31 -140.28 48.19 15 A ASN 55 -112.65 66.34 16 A ALA 16 -40.01 158.07 16 A ASN 55 -105.70 69.38 17 A ALA 16 -41.10 151.80 17 A ASN 55 -108.18 60.88 18 A LEU 6 -42.25 -73.32 18 A ALA 16 -43.78 156.09 18 A VAL 32 -156.95 85.31 18 A CYS 54 -170.62 139.03 18 A ASN 55 -101.73 58.01 19 A ALA 16 -45.88 151.21 19 A ALA 28 -36.90 -36.95 19 A VAL 32 -151.75 88.43 19 A ASN 55 -104.19 64.45 20 A ALA 16 -42.49 150.88 20 A HIS 31 -142.61 54.54 20 A VAL 32 -152.70 87.83 20 A CYS 54 -170.37 144.61 20 A ASN 55 -105.74 58.54 NMR STRUCTURE OF CARDIOTOXIN IN DPC-MICELLE 1 N N 2 N N disulf 2.034 A CYS 3 A SG CYS 3 1_555 A CYS 21 A SG CYS 21 1_555 disulf 1.979 A CYS 14 A SG CYS 14 1_555 A CYS 38 A SG CYS 38 1_555 disulf 2.080 A CYS 42 A SG CYS 42 1_555 A CYS 53 A SG CYS 53 1_555 disulf 2.088 A CYS 54 A SG CYS 54 1_555 A CYS 59 A SG CYS 59 1_555 TOXIN all-beta sheet protein, membrane perturbation, TOXIN CX2_NAJOX UNP 1 1 P01441 LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN 1 60 1FFJ 1 60 P01441 A 1 1 60 2 3 anti-parallel anti-parallel anti-parallel A LYS 2 A LYS 2 A LYS 4 A LYS 4 A SER 11 A SER 11 A THR 13 A THR 13 A PRO 33 A PRO 33 A ILE 39 A ILE 39 A LEU 20 A LEU 20 A MET 26 A MET 26 A VAL 49 A VAL 49 A CYS 54 A CYS 54 1 P 1